The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust CAGR of 13.7%, reaching US$9.37 billion in 2024 and an impressive US$17.78 ...

Reports of impending layoffs, a buyout offer, and a return-to-office mandate have put a damper on FDA staff morale ...

AI accelerates drug development, cutting costs and boosting success rates. Discover how AI is reshaping the future of ...

As of 2023 year-end, the firm had $1.2 billion of debt, $1.6 billion of cash and cash equivalents, and $1.5 billion of deferred taxes that are largely related to its Sartorius investment. We forecast ...

Investors know the biotech industry is a waiting game—smaller companies in this space often work to secure the funding to ...

Endicott senior Jack Smiley is all smiles as he prepares to take the ice Saturday for the first time since suffering a stroke ...

Biotechnology is a rapidly evolving sector with significant advancements anticipated between 2025 and 2035. As innovations in ...

In amongst a clutch of discontinued phase 3 programmes in Roche's fourth-quarter results update was the news that it has stopped a study of AKT inhibitor ipatasertib as a treatment for first-line ...

Explore GymLife Mitchelstown, one of Ireland's only 24-hour gyms, offering flexible access for your fitness journey.